Generate Biomedicines, Inc.
GENB
17 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Sep 3 8:05 PM | Frances ArnoldDirector | Sale | 1,000 | $16.00 | $16.0K | 231,472(D) | View → |
| Sep 2, 2026 | Sep 2 8:20 PM | ARNOLD FRANCES | Proposed Sale | 32,210 | $16.16 | $520.6K | — | View → |
| Sep 1, 2026 | Sep 1 8:27 PM | ARNOLD FRANCES | Proposed Sale | 1,000 | $16.00 | $16.0K | — | View → |
| Mar 4, 2026 | Mar 6 9:55 PM | Michael NallyDirector, Chief Executive Officer | Purchase | 20,000 | $12.00 | $240.0K | 572,707(D) | View → |
| Mar 2, 2026 | Mar 2 11:05 PM | Beth GrousChief People Officer | Purchase | 300 | $16.00 | $4.8K | 300(I) | View → |
| Mar 2, 2026 | Mar 2 10:54 PM | Jason SilversPresident & CFO | Purchase | 2,000 | $16.00 | $32.0K | 1,000(I) | View → |
| Mar 2, 2026 | Mar 2 10:52 PM | Noubar AfeyanDirector, 10% Owner | Purchase | 4,687,500 | $16.00 | $75.0M | 1,562,500(I) | View → |
| Mar 2, 2026 | Mar 2 10:47 PM | Jane L MendilloDirector | Purchase | 1,500 | $16.00 | $24.0K | 1,500(D) | View → |
| Mar 2, 2026 | Mar 2 10:42 PM | Noubar AfeyanDirector, 10% Owner | Purchase | 4,687,500 | $16.00 | $75.0M | 1,562,500(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Mar 2 11:09 PM | Rupert VesseyDirector | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Feb 26, 2026 | Mar 2 11:05 PM | Beth GrousChief People Officer | Grant/Award | 114,020 | $16.00 | 114,020(D) | View → |
| Feb 26, 2026 | Mar 2 11:02 PM | Frances ArnoldDirector | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Feb 26, 2026 | Mar 2 10:58 PM | Laurie Anne LeeChief Medical Officer | Grant/Award | 42,230 | $16.00 | 42,230(D) | View → |
| Feb 26, 2026 | Mar 2 10:58 PM | Sean MartinChief Legal Officer & GC | Grant/Award | 190,034 | $16.00 | 190,034(D) | View → |
| Feb 26, 2026 | Mar 2 10:55 PM | Nancy A SimonianDirector | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Feb 26, 2026 | Mar 2 10:54 PM | Jason SilversPresident & CFO | Grant/Award | 570,101 | $16.00 | 274,493(D) | View → |
| Mar 2, 2026 | Mar 2 10:52 PM | Noubar AfeyanDirector, 10% Owner | Conversion | 50,080,163 | — | 0(I) | View → |
| Feb 26, 2026 | Mar 2 10:52 PM | Noubar AfeyanDirector, 10% Owner | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Feb 26, 2026 | Mar 2 10:51 PM | Gevorg GrigoryanChief Technology Officer | Grant/Award | 491,976 | $16.00 | 196,368(D) | View → |
| Mar 2, 2026 | Mar 2 10:50 PM | Michael NallyDirector, Chief Executive Officer | Conversion | 1,000,000 | — | 0(I) | View → |
| Feb 26, 2026 | Mar 2 10:50 PM | Michael NallyDirector, Chief Executive Officer | Grant/Award | 1,689,190 | $16.00 | 844,595(D) | View → |
| Mar 2, 2026 | Mar 2 10:50 PM | Stephane BancelDirector | Conversion | 1,100,000 | — | 0(I) | View → |
| Feb 26, 2026 | Mar 2 10:50 PM | Stephane BancelDirector | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Feb 26, 2026 | Mar 2 10:47 PM | Jane L MendilloDirector | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Feb 26, 2026 | Mar 2 10:47 PM | Marsha FanucciDirector | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Feb 26, 2026 | Mar 2 10:45 PM | Paul Gray ParkerDirector | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |
| Mar 2, 2026 | Mar 2 10:42 PM | Noubar AfeyanDirector, 10% Owner | Conversion | 50,080,163 | — | 0(I) | View → |
| Feb 26, 2026 | Mar 2 10:42 PM | Noubar AfeyanDirector, 10% Owner | Grant/Award | 29,561 | $16.00 | 29,561(D) | View → |